• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤黑色素瘤的家族风险和归因风险:先证者及年龄的影响

Familial and attributable risks in cutaneous melanoma: effects of proband and age.

作者信息

Hemminki Kari, Zhang Hong, Czene Kamila

机构信息

Department of Biosciences at Novum, Karolinska Institute, 141 57 Huddinge, Sweden.

出版信息

J Invest Dermatol. 2003 Feb;120(2):217-23. doi: 10.1046/j.1523-1747.2003.12041.x.

DOI:10.1046/j.1523-1747.2003.12041.x
PMID:12542525
Abstract

We studied familial risks in invasive and in situ cutaneous melanoma by comparing the occurrence of melanoma, or discordant cancer, between parents and offspring, and between siblings, based on the Swedish Family Cancer Database of over 10 million individuals. Offspring were 0-66 y of age. Cancers were obtained from the Swedish Cancer Registry from 1961 to 1998. The study was based on 24,818 invasive and 5510 in situ cases of melanoma. Standardized incidence ratios were calculated for familial risk. The standardized incidence ratios for offspring was 2.40 (95% confidence intervals: 2.10-2.72) when only the parent had melanoma and it was 2.98 (95% confidence intervals: 2.54-3.47) when only a sibling was affected; when both a parent and a sibling were affected the standardized incidence ratios was 8.92 (95% confidence intervals: 4.25-15.31). The respective population attributable risks were 1.38, 1.20, and 0.10%. The familial risk showed a clear age dependence and somewhat higher risk in in situ melanoma than in the invasive counterpart. The highest standardized incidence ratio of 61.78 (5.82-227.19) was noted for offspring whose parent had multiple melanomas. Superficially spreading melanoma showed the highest familial risk both among invasive and in situ tumors. Melanoma associated with breast, nervous system, and skin cancers, and in situ melanoma possibly also with connective tissue and thyroid tumors and multiple myeloma.

摘要

我们通过比较父母与子女之间以及兄弟姐妹之间黑色素瘤或不一致癌症的发生情况,基于瑞典超过1000万个体的家庭癌症数据库,研究了侵袭性和原位皮肤黑色素瘤的家族风险。子女年龄在0至66岁之间。癌症数据来自1961年至1998年的瑞典癌症登记处。该研究基于24818例侵袭性黑色素瘤病例和5510例原位黑色素瘤病例。计算了家族风险的标准化发病率比。当只有父母患有黑色素瘤时,子女的标准化发病率比为2.40(95%置信区间:2.10 - 2.72);当只有兄弟姐妹患病时,标准化发病率比为2.98(95%置信区间:2.54 - 3.47);当父母和兄弟姐妹都患病时,标准化发病率比为8.92(95%置信区间:4.25 - 15.31)。相应的人群归因风险分别为1.38%、1.20%和0.10%。家族风险呈现明显的年龄依赖性,原位黑色素瘤的风险略高于侵袭性黑色素瘤。父母患有多发性黑色素瘤的子女的标准化发病率比最高,为61.78(5.82 - 227.19)。在侵袭性和原位肿瘤中,浅表扩散性黑色素瘤的家族风险最高。黑色素瘤与乳腺癌、神经系统癌和皮肤癌相关,原位黑色素瘤可能还与结缔组织、甲状腺肿瘤和多发性骨髓瘤相关。

相似文献

1
Familial and attributable risks in cutaneous melanoma: effects of proband and age.皮肤黑色素瘤的家族风险和归因风险:先证者及年龄的影响
J Invest Dermatol. 2003 Feb;120(2):217-23. doi: 10.1046/j.1523-1747.2003.12041.x.
2
Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.按阳光暴露身体部位划分的侵袭性和原位皮肤黑色素瘤的发病率趋势及家族风险。
Int J Cancer. 2003 May 10;104(6):764-71. doi: 10.1002/ijc.10976.
3
Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.患者出现多发性原发性(甚至原位)黑色素瘤会给家庭成员带来重大风险。
Eur J Cancer. 2014 Oct;50(15):2659-67. doi: 10.1016/j.ejca.2014.07.007. Epub 2014 Aug 4.
4
Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.家族性风险估计中的偏倚评估:一项基于瑞典人群登记册的常见癌症研究。
J Natl Cancer Inst. 2008 Sep 17;100(18):1318-25. doi: 10.1093/jnci/djn290. Epub 2008 Sep 9.
5
Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.根据既往黑色素瘤数量评估家族性和散发性黑色素瘤患者的下一个黑色素瘤风险。
JAMA Dermatol. 2015 Jun;151(6):607-15. doi: 10.1001/jamadermatol.2014.4777.
6
A population-based study of familial cutaneous melanoma.一项基于人群的家族性皮肤黑色素瘤研究。
Melanoma Res. 2001 Apr;11(2):133-40. doi: 10.1097/00008390-200104000-00007.
7
Familial risk of cancer shortly after diagnosis of the first familial tumor.首例家族性肿瘤诊断后不久的癌症家族风险。
J Natl Cancer Inst. 2005 Nov 2;97(21):1575-9. doi: 10.1093/jnci/dji338.
8
Modification of cancer risk in offspring by parental cancer (Sweden).父母患癌对后代癌症风险的影响(瑞典)
Cancer Causes Control. 1999 Apr;10(2):125-9. doi: 10.1023/a:1008896712363.
9
Time trends and familial risks in squamous cell carcinoma of the skin.皮肤鳞状细胞癌的时间趋势和家族风险
Arch Dermatol. 2003 Jul;139(7):885-9. doi: 10.1001/archderm.139.7.885.
10
Risk of incident and fatal melanoma in individuals with a family history of incident or fatal melanoma or any cancer.有家族史的个体中黑色素瘤的发病风险和致死风险,不论家族史中黑色素瘤发病或任何癌症发病。
Br J Dermatol. 2011 Aug;165(2):342-8. doi: 10.1111/j.1365-2133.2011.10350.x. Epub 2011 Jun 30.

引用本文的文献

1
The epidemiology of melanoma in young adults.年轻成年人黑色素瘤的流行病学
Expert Rev Dermatol. 2013;8(6):707-716. doi: 10.1586/17469872.2013.844465.
2
Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort.晚期黑色素瘤病情进展后持续免疫检查点抑制对总生存期的实际疗效:来自Melbase队列的评估
Melanoma Res. 2025 Feb 1;35(1):50-59. doi: 10.1097/CMR.0000000000000973. Epub 2024 Nov 11.
3
Use of antihypertensive drugs and risk of cutaneous melanoma: a nationwide nested case-control study.
使用抗高血压药物与皮肤黑色素瘤风险:一项全国性巢式病例对照研究。
Int J Epidemiol. 2023 Jun 6;52(3):887-898. doi: 10.1093/ije/dyac223.
4
Combination of Optical Biopsy with Patient Data for Improvement of Skin Tumor Identification.光学活检与患者数据相结合以改善皮肤肿瘤识别
Diagnostics (Basel). 2022 Oct 15;12(10):2503. doi: 10.3390/diagnostics12102503.
5
Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.免疫调节药物的使用与皮肤黑色素瘤风险:一项全国性巢式病例对照研究。
Clin Epidemiol. 2020 Dec 18;12:1389-1401. doi: 10.2147/CLEP.S269446. eCollection 2020.
6
Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example.向患者告知其基因检测结果:以黑色素瘤中CDKN2A基因c.256G>A突变为例。
Hered Cancer Clin Pract. 2020 Jul 31;18:15. doi: 10.1186/s13053-020-00146-x. eCollection 2020.
7
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study.抗抑郁药的使用与皮肤黑色素瘤风险:一项基于前瞻性登记的病例对照研究。
Clin Epidemiol. 2020 Feb 21;12:193-202. doi: 10.2147/CLEP.S241249. eCollection 2020.
8
Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study.心血管、抗抑郁和免疫抑制药物的使用与皮肤黑色素瘤风险的关系:一项前瞻性病例对照研究的方案。
BMJ Open. 2019 Feb 20;9(2):e025246. doi: 10.1136/bmjopen-2018-025246.
9
Conceptual approach to early melanoma detection: models, tools, issues and challenges.早期黑色素瘤检测的概念性方法:模型、工具、问题与挑战
Melanoma Manag. 2015 Nov;2(4):327-337. doi: 10.2217/mmt.15.24. Epub 2015 Nov 24.
10
High accuracy of family history of melanoma in Danish melanoma cases.丹麦黑色素瘤病例中黑色素瘤家族史的高准确性。
Fam Cancer. 2015 Dec;14(4):609-13. doi: 10.1007/s10689-015-9820-1.